Quantbot Technologies LP Dbv Technologies S.A. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$2.75 - $6.57 $7,573 - $18,093	-2,754 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.38 - $3.01 $3,800 - $8,289	2,754 New	2,754 $7,000
Q1 2018 May 11, 2018	SELL	$20.86 - $26.6 $77,328 - $98,606	-3,707 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$20.9 - $49.36 $5,099 - $12,043	244 Added 7.05%	3,707 $91,000
Q3 2017 Nov 07, 2017	BUY	$39.62 - $46.17 $137,204 - $159,886	3,463	3,463 $146,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.